Prev: An Apology
Next: Losing Weight By Eating
From: Maija Haavisto on 25 Jun 2008 04:11
Adding to the recent good news (raloxifene found effective for FM,
Cymbalta approved as an official treatment), preliminary results
of a lacosamide trial were published. This is what I wrote about it
on my book's website (shortened a bit here):

"There are good news for fibromites again (it looks like we are on a
roll here!). A phase IIa trial found the novel anticonvulsant lacosamide
effective for fibromyalgia. The drug was also found "very well
tolerated." Lacosamide has not yet been approved anywhere. FDA and the
European Medicines Agency are currently reviewing the company's new drug
application and the drug could be approved for use in partial-onset
seizures (a type of epilepsy) and diabetic neuropathy in the near future,
with the trade name Vimpat.

Before lacosamide can be officially approved for fibromyalgia it needs
to go through more trials and it would take until the end of next year
at the earliest before it could receive approval for this indication. Of
course, even if it is not approved for fibromyalgia, doctors can still
prescribe it off-label for fibromyalgia once it is approved for use in
another condition."

Personally, I find this very good news, even if preliminary. Especially
the good tolerability is a plus. And as the drug presents a completely
novel mode of action (actually a dual mode of action), it could help
people who haven't benefited (or haven't been able to tolerate) any of
the current anticonvulsants.

--
%. _ /) That's why I didn't kill myself sooner, the pressure
`%-('`._/ ) _ of spelling mistakes. -"5 Suicide Notes" by Saracen Tate
`\ \ `'/ Maija Haavisto * DiamonDie(a)IRCnet * http://www.fiikus.net
`.___.'mh My CFS/ME/FM book: http://www.brokenmarionettebook.com
 | 
Pages: 1
Prev: An Apology
Next: Losing Weight By Eating